Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease

CONCLUSION: Although CLD patients with SARS-CoV-2 infection were not associated with increased risk of HCC, they were more likely to receive palliative treatment than those without. The detrimental effects of SARS-CoV-2 infection persisted in post-acute phase.PMID:38495273 | PMC:PMC10941734 | DOI:10.4254/wjh.v16.i2.211
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research